Initial very low calorie diet (VLCD) improves ultimate weight loss.

Area of Science:

• Obesity treatment
• Nutritional science
• Metabolic disorders

Background:

• Obesity is a complex metabolic disorder requiring effective management strategies.
• Traditional weight loss programs often face challenges with patient adherence and long-term success.
• Very low-calorie diets (VLCDs) offer a potential intervention for significant initial weight reduction.

Purpose of the Study:

• To evaluate the effectiveness of a VLCD formula diet (NUPO) in an outpatient setting.
• To compare weight loss outcomes based on the duration of VLCD treatment.
• To assess the impact of VLCD-induced weight loss on medication requirements.

Main Methods:

• Thirty-eight obese outpatients were enrolled in the study.
• Treatment involved an initial VLCD phase followed by a calorie-restricted diet (1000-1100 kcal).
• Patients were divided into two groups based on VLCD duration: <2 months (Group 1) and ≥2 months (Group 2).

Main Results:

• Group 2 (VLCD ≥2 months) achieved significantly greater total weight loss (17.1 kg) compared to Group 1 (8.7 kg).
• Weight loss on VLCD alone was also significantly higher in Group 2 (12.3 kg) versus Group 1 (7.3 kg).
• Significant weight reduction in both groups led to the elimination or reduction of various medications.

Conclusions:

• VLCDs are an effective and encouraging method to initiate weight loss programs for obese individuals.
• A VLCD duration of at least two months is crucial for maximizing weight loss outcomes.
• The study highlights the significant impact of VLCD-initiated weight loss on improving health markers and reducing pharmaceutical dependence.